Lumos: Q2 Earnings Snapshot
By AP News
Published - Aug 02, 2024, 02:48 AM ET
Last Updated - Aug 02, 2024, 02:48 AM EDT
AUSTIN, Texas (AP) — AUSTIN, Texas (AP) — Lumos Pharma, Inc. (LUMO) on Thursday reported a loss of $7.6 million in its second quarter.
The Austin, Texas-based company said it had a loss of 93 cents per share.
The results surpassed Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of $1.26 per share.
The biopharmaceutical company posted revenue of $488,000 in the period.
